Pfizer & Endo Settle with Texas, Affymax Partners with Takeda: Healthcare Business Recap

Pfizer (NYSE:PFE): Current Price $26.00

Medical fraud allegations between Pfizer and Endo Pharmaceuticals (NASDAQ:ENDP) and the state of Texas have been resolved, with an excess of $36 million going to the latter, says the Attorney General. Each firm will pay the state $18.2 million, along with attorney fees and relator shares. The accord comes after Texas and the Attorney General charged the companies with defrauding Medicaid in previously sealed cases, in which they allegedly misreported the price of generic drugs to the Medicaid program.

pfizer

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business